Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng(University of Cambridge), Jenny Kourampa(Cambridge University Hospitals NHS Foundation Trust), Niluka Goonawardane(Imperial College London), Jo Calder(Cambridge University Hospitals NHS Foundation Trust), Teresa Brevini(University of Cambridge), Oscar Charles(University College London), Christoph Hess(University of Cambridge), Willem H. Ouwehand(NHS Blood and Transplant), Michael P. Weekes(University of Cambridge), Stewart Fuller(Cambridge University Hospitals NHS Foundation Trust), Mako Toyoda(Kumamoto University), Akifumi Takaori‐Kondo(Kyoto University), Jin Kuramochi(Saiseikai Utsunomiya hospital), Akatsuki Saito(University of Miyazaki), Nathalie Kingston, Stephen Baker(University of Connecticut), Adam Abdullahi(Harvard Global Health Institute), Charlotte Summers(Queen Mary University of London), Patrick H. Maxwell(Centre for Human Genetics), Caroline Saunders(Cambridge University Hospitals NHS Foundation Trust), James Thaventhiran(University of Cambridge), Mark Toshner, Jane Kennet(Cambridge University Hospitals NHS Foundation Trust), Paul Lyons(Cambridge School), Guido Papa(University of Siena), Saman Fatihi(Institute of Genomics and Integrative Biology), Toong Seng Tan(Brigham and Women's Hospital), Ashlea Bucke(Cambridge University Hospitals NHS Foundation Trust), Samantha K. Zepeda(University of Washington), Kotaro Shirakawa(Kyoto University), Pehuén Pereyra Gerber(University of Cambridge), Jason Domingo(Cambridge University Hospitals NHS Foundation Trust), Takamasa Ueno(Kumamoto University), Steven A. Kemp(Africa Health Research Institute), Sarah Hewitt(Cambridge University Hospitals NHS Foundation Trust), Surabhi Rathore(Institute of Genomics and Integrative Biology), Paul J. Lehner(University of Cambridge), Ashley Shaw(Cambridge University Hospitals NHS Foundation Trust), Donna L. Mallery(MRC Laboratory of Molecular Biology), Nicholas J. Matheson(NHS Blood and Transplant), Daichi Yamasoba(National Institute of Infectious Diseases), Isabella A.T.M. Ferreira(University of Cambridge), Laura Canna(Cambridge University Hospitals NHS Foundation Trust), Julie Harris(Cambridge University Hospitals NHS Foundation Trust), Anne Elmer(Cambridge University Hospitals NHS Foundation Trust), Shigeki Mitsunaga(National Institute of Genetics), Sherly Jose(Cambridge University Hospitals NHS Foundation Trust), Izumi Kimura(National Institute of Infectious Diseases), Gordon Dougan(University of Cambridge), Terumasa Ikeda(Kumamoto University)
Cited by 1,165
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays
|Cell|2022|1.7k
Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation
|Journal of Medical Virology|2020|1.5k
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
|Nature|2021|1.4k